U.S. markets open in 1 hour 8 minutes

One World Pharma, Inc. (OWPC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2591-0.0409 (-13.64%)
At close: 3:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3000
Open0.3100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2260 - 0.3200
52 Week Range0.0605 - 1.0000
Volume104,634
Avg. Volume168,581
Market Cap13.339M
Beta (5Y Monthly)-0.28
PE Ratio (TTM)N/A
EPS (TTM)-0.1800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Colombian Ministry of Health Calls for International Export of Flower
    GlobeNewswire

    Colombian Ministry of Health Calls for International Export of Flower

    Permission to Export Flower Would be Huge Catalyst for OWP LAS VEGAS, NV, March 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – One World Pharma Inc. (OTC: OWPC), (“OWP” or the “Company”), a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is encouraged by a formal recommendation to allow for the international export of dry cannabis flower. In a recently published letter from the Colombian Ministry of Health and Social Protection to the President of Colombia, related to Law 1787 and Decree 613, the Ministry calls for modifications that would allow for the exportation of dry flower. One World Pharma believes the freedom to sell its dry flower internationally would be of enormous benefit to the Company and the entire industry in Colombia and would significantly increase the Company’s ingredient product offerings in scale, and reduce time to market. Dry flower represents over 50% of the demand in many markets such as the United States, Germany and Australia. Currently, such sales are not allowed. One World Pharma, through its strategic relationships with small farmers, indigenous groups, FEDECORE, and the Colombian Federation of Regional Advisors, has access to significant acreage for cultivation. Given One World Pharma’s operational strengths, the modifications to Colombia’s laws would make it possible to go from seed to sale within 120 days. The Company continues to increase its production capacity at its initial farm in Popayan and is currently negotiating contracts that would provide it with its own extraction capabilities. “Permission to export our flower would indeed be a milestone for One World Pharma,” said Isiah Thomas, CEO of One World Pharma. “We are well-positioned to act on this excellent opportunity with the relationships, technology and genetics to grow the finest flower at scale and leveraging the tremendous equatorial advantages provided by Colombia. This would be a great complement to our existing efforts to sell high quality extracted products under existing law.” About One World Pharma Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia. One World Pharma Investor Relations & Financial Media Kurt Divich, CEO Integrity Media Inc. team@integritymedia.com Toll Free: (888) 216-3595 www.IntegrityMedia.com Information about Forward-Looking Statements This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the failure to close the remaining funding installments with ISIAH International, the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

  • Emerging Markets Report: The Game Changer
    GlobeNewswire

    Emerging Markets Report: The Game Changer

    An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- In today’s edition of The Emerging Markets report we are getting right to the point regarding One World Pharma Inc. (OTCQB: OWPC) which we believe is unlike any deal we’ve previously presented in our pages. Frankly, a recent event is a true game changer. First, a quick primer: One World Pharma is led by legendary NBA superstar and international businessman Isiah Thomas. Thomas is renowned not just for being one of the greatest basketball players of all time, but for having enormous business successes. His name attached to any deal should turn heads and inspire interest.OWP is based in Colombia where as Mr. Thomas says, the perfect equatorial growing conditions give it a huge “home court advantage” to harvest the finest cannabis at scale and sell these ingredients at the most competitive pricing.Notably, one World Pharma has just received important growing approvals in Colombia which “…now unlock access to a vast international market that we’ve been waiting to enter.” The company is truly at a tipping point.And the game changer is that Thomas just committed to putting THREE MILLION DOLLARS of his own money into the deal. This game changer, we believe, could be truly transformative for One World Pharma at a point when it appears poised to go to the next level of production and monetization. First, a cash infusion of that significance can help the Company seize the moment and capitalize on its current, highly exclusive permissions. One World Pharma intends to use the funds for expansion of farm operations, additional certifications for THC seeds already approved by the government of Colombia, Global GAP (Good Agricultural Practices) certification and the build-out of a GMP certified state-of-the-art THC/CBD extraction facility. In short, One World Pharma is going to use the funds to do the things that will generate sales and revenue. Secondly, it’s important to note the timing of this commitment by Thomas, as it comes quite some time after he took the big chair as CEO in June of 2020. Now, after nine months of running the business, getting hands on experience, and watching the corporate milestones get hit and growing permissions granted, Thomas has made what can only be described as an enormous financial commitment, betting on himself and the Company. It’s a game changer in the making. For more information on One World Pharma please visit: www.OneWorldPharma.com About the Emerging Markets Report: Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stock brokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php Must Read OTC Markets/SEC policy on stock promotion and investor protection https://www.otcmarkets.com/learn/policy-on-stock-promotionhttps://www.otcmarkets.com/learn/investor-protectionhttps://www.sec.gov/news/press-release/2017-79https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. EMC has been paid $195,000 and 425,000 restricted shares by One World Pharma. EMC has a contract to receive $50,000 over the next month. KP Investment partners invested 50,000 dollars in One World Pharma. EMC acquired a unit that translates into shares at .20 and a warrant. CEO of Emerging Markets James Painter has a 50% ownership stake in KP Investment partners. A contributor to this report, Integrity Media, has been provided 780,000 shares and is under contract to receive $4,000 a month for a period of twenty-four months for investor relations services on the behalf of One World Pharma by One World Pharma and its principals. Integrity Media is currently under a two-month extension at $5,000 per month. http://emergingmarketsllc.com/disclaimer.php Emerging Markets Consulting, LLCFlorida Office390 North orange Ave Suite 2300Orlando, FL 32801E-mail: jamespainter@emergingmarketsllc.comWeb: www.emergingmarketsllc.com

  • One World Pharma Secures $3 Million Investment Commitment From ISIAH International
    GlobeNewswire

    One World Pharma Secures $3 Million Investment Commitment From ISIAH International

    LAS VEGAS, NV, Feb. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- One World Pharma Inc. (OTC: OWPC), (“OWP” or the “Company”), a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce an agreement with ISIAH International, LLC, the holding company of its CEO, Isiah Thomas, to invest $3 million into One World Pharma, Inc. The $3 million investment will fund the expansion of farm operations, additional certifications for THC seeds already approved by the government of Colombia, Global GAP (Good Agricultural Practices) certification and the build-out of a GMP certified state-of-the-art THC/CBD extraction facility. The investment will be made in installments over six months, with the first tranche of $250,000 having already been funded. The farm expansion through this funding is expected to allow One World Pharma to significantly increase revenue in the second quarter of 2021 through the increased sale of seeds, newly approved cuttings, and extracted oil. Isiah Thomas makes this substantial financial commitment through ISIAH International based on his belief in the bright future of the global cannabis market, which leading research firms assert will reach $47 billion in annual sales by 2025. ISIAH International is a holding company with interests in a diversified portfolio of companies. Wholly owned by Chief Executive Officer Isiah Thomas, ISIAH International invests in companies with strong market positions and growth potential. “We could not be more thrilled. When Isiah Thomas assumed the role of CEO he lent us his good name and his world-renowned leadership and business acumen. Today, he provides the funding for the Company to truly execute on its plan to become a leading international supplier of the finest cannabis ingredients,” stated Dr. Kenneth Perego, OWP’s Executive Chairman. Isiah Thomas, on behalf of ISIAH International, stated, “After extensive analysis of Colombia, the world market and these most recent developments at the Company, I passionately believe there is a tremendous opportunity to build a world class, valuable, environmentally and socially conscious company that is a significant player in the global cannabis and industrial hemp industries. There are few, if any, reliable, industrial scale, global supply chain companies in this space and we intend to be one. I am pleased to initiate this next chapter of growth.” About One World Pharma Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia. One World Pharma Investor Relations & Financial Media Kurt Divich, CEO Integrity Media Inc. team@integritymedia.com Toll Free: (888) 216-3595 www.IntegrityMedia.com Information about Forward-Looking Statements This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the failure to close the remaining funding installments with ISIAH International, the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.